Skip to main content
Gil Melmed MD
Dr Melmed, from Cedars-Sinai Medical Center in Los Angeles, discusses his presentation from the virtual 2021 Interdisciplinary Autoimmune Summit on how standardizing some aspects of biologic therapies can lead to more personalized care for patients with inflammatory bowel disease.
Michelle Petri MD
The early and accurate diagnosis is essential in the management of systemic lupus erythematosus, according to Michelle Petri, MD, who spoke at the virtual Interdisciplinary Autoimmune Summit on April 17, 2021.
At the Interdisciplinary Autoimmune Summit, Ruth Ann Vleugels, MD, MPH, MBA, presented “Strategies for Improving IMID Outcomes: The Potential of JAK Inhibitors,” sharing a number of pearls when it comes to utilizing JAK inhibitors for the treatment of immune-mediated inflammatory diseases.
kinghs2
Brett King, MD, PhD, discusses alopecia areata and polyautoimmunity following his presentation at IAS 2021.
Miguel Regueiro
In this video, Dr Regueiro, professor and chair of the Department of Gastroenterology, Hepatology, and Nutrition at the Cleveland Clinic, reviews his presentation at the Interdisciplinary Autoimmune Summit on postoperative Crohn disease.
At the Interdisciplinary Autoimmune Summit 2021, Dr Lio spoke about emerging therapies for moderate to severe AD. In an interview with ALN, he answered several questions regarding advanced management of the disease.
Wei_HS
Erin Wei, MD, discusses Pemphigus Vulgaris prior to her IAS session titled Pemphigus Vulgaris: Strategies for Disease Identification and Management.
Sartor
In this video, Dr Sartor, from the University of North Carolina at Chapel Hill, discusses the role of bacteria and other organisms in the microbiome and how a variety of therapies, from biologic therapies to fecal microbiota transplantation, may work to alleviate dysbiosis and effectively treat immune-mediated inflammatory diseases from Crohn disease to psoriasis, as he explained at the Interdisciplinary Autoimmune Summit.
In her presentation at the Interdisciplinary Autoimmune Summit 2021, Junko Takeshita, MD, PhD, MSCE, outlined examples of health care disparities and offered insights on how to address them in clinical practice and training.
In the opening session of the Interdisciplinary Autoimmune Summit 2021, Leonard Calabrese, DO, shared some of the most recent updates in our understanding of COVID-19, particularly within the lens of autoimmunity and immune-mediated inflammatory diseases.
Back to Top